|
Investment horizon:
|
30 Days
Login
to change
|
|
|
Relative Risk vs. Return Landscape
If you would invest
5,155 in AstraZeneca PLC on
April 25, 2013 and sell it today you would
earn a total of 62.00 from holding AstraZeneca PLC or generate
1.2% return on investment over
30 days. AstraZeneca PLC is generating 0.09% of daily returns assuming volatility of
0.65% on return distribution over 30 days investment horizon. In other words, 8% of equities are less volatile than the company and above 95% of equities are expected to generate higher returns over the next 30 days.
Daily Expected Return (%)
Considering 30-days investment horizon, AstraZeneca PLC is expected to generate 2.11 times less return on investment than the market. In addition to that, the company is 1.1 times more volatile than its market benchmark. It trades about 0.14 of its total potential returns per unit of risk. The S&P 500 is currently generating roughly 0.32 per unit of volatility.
AstraZeneca Operating Margin
Based on recorded statements AstraZeneca PLC has Operating Margin of 32.53%. This is 221.34% lower than that of Healthcare sector, and 230.85% lower than that of
Drug Manufacturers - Major industry, The Operating Margin for all stocks is 1008.66% lower than the firm.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.
AstraZeneca Return On Equity vs Return On Asset
AstraZeneca PLC is rated
fourth in return on equity category among related companies. It is rated
third in return on asset category among related companies reporting about
0.41 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for AstraZeneca PLC is roughly
2.43